Related Experiment Video
Updated: May 3, 2026

10:31
Antigenic Liposomes for Generation of Disease-specific Antibodies
Published on: October 25, 2018
11.3K
Mechanisms of allergen-specific desensitization
Christina Uermösi1, Roger R Beerli, Monika Bauer
1Cytos Biotechnology AG, Zurich-Schlieren, Switzerland.
The Journal of Allergy and Clinical Immunology
|July 14, 2010
Summary
Specific IgG antibodies can block allergic reactions by inhibiting mast cell activation, even when IgE levels remain high. This discovery offers insights into allergy immunotherapy and future vaccine development.
Area of Science:
- Immunology
- Allergy Research
- Vaccine Development
Background:
- Allergen-specific immunotherapy (SIT) is a leading therapy for allergies.
- Mechanisms of IgG antibody-mediated inhibition of allergic reactions remain unclear.
Purpose of the Study:
- Investigate how SIT-induced allergen-specific IgGs inhibit allergic reactions.
- Clarify the role of IgG subclasses in blocking allergic responses.
Main Methods:
- Generated monoclonal antibodies (mAbs) against three distinct epitopes of the cat allergen Fel d 1.
- Produced mAbs as both IgE and various IgG isotypes for comparative analysis.
- Assessed mast cell activation and degranulation in vitro and in vivo.
Main Results:
- IgEs against two epitopes were sufficient for maximal mast cell sensitization.
- A single IgG antibody, recognizing a different epitope, potently inhibited Fel d 1-induced mast cell activation.
- Inhibition by IgG required Fcgamma receptor-IIB and was enhanced by larger allergen-IgG complexes.
- IgGs blocked basophil degranulation in human subjects with cat allergy.
Conclusions:
- Findings reconcile conflicting theories on allergy immunotherapy.
- Explain why IgE levels may not decrease despite clinical SIT efficacy.
- Provide crucial insights for designing effective allergy vaccines.
Related Concept Videos
Allergic Reactions
26.4K
Overview
26.4K
GPCR Desensitization
6.1K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.1K
Allergic Drug Reactions
1.6K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.6K
Hypersensitivities
7.3K
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
7.3K
Drug Toxicity: Allergic Reactions
209
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
209
Allergic Reactions: Anaphylaxis
280
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
280

